Detalhe da pesquisa
1.
Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approach.
World J Urol
; 41(5): 1301-1308, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920491
2.
Grade group 1 prostate cancer on biopsy: are we still missing aggressive disease in the era of image-directed therapy?
World J Urol
; 40(10): 2423-2429, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35980449